98%
921
2 minutes
20
The polymerase chain reaction (PCR) is a potentially interesting diagnostic tool for detecting congenital Trypanosoma cruzi infection at birth. We have compared the sensitivity and capacity of a group of T. cruzi PCR primers in detecting the complete spectrum of known T. cruzi lineages, and to improve and simplify the detection of infection in neonatal blood. We found that the two primers, Tcz1/Tcz2 and Diaz1/Diaz2, which target the 195-basepair satellite repeat, detected all parasitic lineages with the same sensitivity. However, the intensity of the amplicon was somewhat higher with Tcz1/Tcz2. For other tested primers (nuclear DNA primers BP1/BP2, O1/O2, Pon1/Pon2, and Tca1/Tca2 and kinetoplast DNA primers S35'/S36' and 121/122), either the intensity of amplicons varied according to T. cruzi lineages or the PCR assay was less sensitive. The use of the Tcz1/Tcz2 primers, which target a tandem repetitive sequence, requires a careful determination of the appropriate amount of Taq polymerase to avoid the formation of smears and multiple amplicon bands. The Tcz1/Tcz2 primers resulted in an intense 200-basepair amplicon with DNA extracted from blood equivalent to 0.02 parasites per assay when used with a simple DNA extraction method and of a low amount of Taq polymerase from a standard PCR kit. To better assess such PCR protocol, we assayed 311 samples of neonatal blood previously tested by parasitologic methods. The reliability of our PCR test was demonstrated, since all the 18 blood samples from newborns with congenital T. cruzi infection were positive, whereas the remaining samples (30 from control newborns of uninfected mothers and 262 of 263 from babies born to infected mothers) were negative. Since our PCR method is simple, reliable, robust, and inexpensive, it appears suitable for the detection of T. cruzi infection in neonatal blood, even in laboratories that are not equipped for performing the PCR.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.4269/ajtmh.2003.68.574 | DOI Listing |
Biology (Basel)
August 2025
SECIHTI Adscribed to Centro de Investigación Sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, Cuernavaca 62100, Morelos, Mexico.
, the main vector of Chagas disease in central Mexico, hosts a diverse and complex gut bacterial community shaped by environmental and physiological factors. To gain insight into these microbes' dynamics, we characterised the gut bacterial communities of wild and insectary insects under different feeding and infection conditions, using 16S rRNA gene sequencing. We identified 91 bacterial genera across 8 phyla, with Proteobacteria dominating most samples.
View Article and Find Full Text PDFCell Biol Int
September 2025
Laboratório de Ultraestrutura Celular Hertha Meyer, Centro de Pesquisas em Medicina de Precisão, Instituto de Biofísica Carlos Chagas Filho- Universidade Federal do Rio de Janeiro, Instituto Nacional de Ciência e Tecnologia em Biologia Estrutural e Biomagens, Centro Nacional de Biologia Estrutur
Chagas disease, caused by the protozoan Trypanosoma cruzi, is a neglected tropical disease with limited treatment options and no available vaccine. Understanding the role of proteins in the parasite's biological cycle is critical for advancing vaccine development and optimizing therapies. The flagellar attachment zone (FAZ) proteins play a pivotal role in motility, pathogenicity, and cell division in trypanosomatids, but their functions in T.
View Article and Find Full Text PDFACS Omega
August 2025
Laboratório de Imunofarmacologia Parasitária, Disciplina de Parasitologia/Faculdade de Ciências Médicas Universidade do Estado do Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.
The hemoflagellate protozoan is the etiologic agent of Chagas disease, one of the neglected tropical diseases endemic to Latin America with a high socioeconomic impact. Treatment remains restricted to two drugs, benznidazole and nifurtimox, which present several side effects and are ineffective in the chronic phase of the disease. The synthetic pterocarpanquinone LQB-118, a hybrid molecule synthesized from lapachol and pterocarpan, exhibits several biological activities, including antiparasitic effects similar to those of its precursors.
View Article and Find Full Text PDFPharmaceuticals (Basel)
July 2025
Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias, Universidad de La Laguna, Avda. Astrofísico Fco. Sánchez, S/N, 38203 La Laguna, Spain.
Chagas disease, caused by the protozoan parasite , remains a major neglected tropical disease, with over six million cases concentrated, primarily in Latin America. Despite decades of research, treatment continues to rely on two outdated drugs-benznidazole and nifurtimox-both of which exhibit limited efficacy and are associated with severe side effects. In this context, drug repurposing presents a promising strategy to accelerate the development of safer and more effective therapies.
View Article and Find Full Text PDFPathogens
August 2025
Department of Biology, Parasitology and Pharmaceutical Botany, Pomeranian Medical University in Szczecin, Powstanców Wielkopolskich 72, 70-111 Szczecin, Poland.
The shortage of organs for use in transplantation has contributed to the development of an international commercial market for organ transplantation. Unfortunately, transplant tourism (TT) is associated with risks for surgical complications, poor graft outcome, increased mortality, and infectious complications. TT increases the risk of several viral (HIV and hepatitis B and C viruses), bacterial ( sp.
View Article and Find Full Text PDF